Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


WAISMANN METHOD® Medical Director Expresses Concern about Shift in Opioid Drug Use
Abuse-Deterrent Formulation of OxyContin Allegedly Responsible for Increase in Heroin Users

BEVERLY HILLS, Calif., Jan. 2, 2013 /PRNewswire/ -- An "abuse-proof" formulation of OxyContin may have helped reduce the number of patients abusing the drug, but Dr. Michael Lowenstein, medical director for WAISMANN METHOD® opiate detoxification and treatment, is voicing alarm at recent data showing it may have consequentially resulted in a sharp increase in heroin and other opioid drug use.

"After the new abuse-resistant OxyContin was released, I expressed concerns that it could encourage patients to migrate to other, sometimes more dangerous opioid drugs," said Dr. Lowenstein. "Two years later this fear has become a reality, as the New England Journal of Medicine reported a huge increase in high-potency prescription opioids while heroin use nearly doubled.  Patient education is more important now than ever before, so we can work to actually help alleviate people of their addictions to opioids rather than replace one narcotic for another."

The NEJM study scrutinized data from 2,566 patients with opioid dependence, and found that abuse of OxyContin as the primary drug decreased from 35.6 percent to 12.8 percent from July 1, 2009 to March 31, 2012. During the same time period, respondent figures showed a rise in use of opioids, like hydrocodone and oxycodone, and powerful opioids, like fentanyl and hydromorphone, which rose from 20.1 percent to 32.3 percent. Data collected from WAISMANN METHOD® patients between January and December 2011 also showed similar trends. During this time, there was an 80 percent decrease in the number of patients treated for OxyContin dependency compared to those in 2010. At the same time, oxycodone patients treated at the facility went up by 35 percent.

According to the NEJM study, heroin was the most common opioid being used among the 66 percent who indicated they had switched after the abuse-resistant OxyContin was released.  Qualitative responses from the study indicated many patients who switched to heroin did so because it was easier to obtain and more economical than prescription drugs. One participant said, "Most people that I know don't use OxyContin to get high anymore. They have moved on to heroin [because] it is easier to use, much cheaper and easily available."

"We want patients struggling with opioid addiction to know that there are true solutions, and that they don't have to continue to put their lives in danger by using prescription painkillers or switching to illicit street drugs like heroin," continued Dr. Lowenstein. "Abuse-resistant drugs are not the answer, and we in the medical community have a responsibility to do more for our patients so they can eventually live drug-free lives."

For more information about WAISMANN METHOD® treatment and detoxification please visit opiates.com.  For interviews contact Nicolette Surh at 877-975-3423 or send an email to Nicolette(at)rkpr(dot)net.

About WAISMANN METHOD® Treatment

WAISMANN METHOD® opiate treatment and detox is a safe and proven protocol for opiate dependency that utilizes the most advanced medical and psychological techniques available. Together Michael H. Lowenstein M.D., Clifford Bernstein M.D. and Clare Waismann, Registered Addiction Specialist (RAS) created a treatment protocol based on a foundation of safety, success and respect.  Our detoxification and aftercare programs are customized to each patient's individual needs and dependency history, combining the most advanced medical treatment with personalized assessment and aftercare. From rapid opiate detoxification under sedation, to medically assisted detoxification and managed care at Domus Retreat, our doctors, therapists and staff work with patients to create personalized treatment and aftercare plans that ensure a healthy and effective transition to life without opiates.  WAISMANN METHOD® patients achieve an extraordinarily high success rate because the treatment doesn't take a cookie cutter approach to addressing opiate dependency. We always put treatment and care over blame and punishment. For more information, please visit opiates.com.

SOURCE WAISMANN METHOD®

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Don’t emphasize network security at the cost of endpoint security; the two can be integrated and work hand in hand. The result is a safer, more secure business ready for the challenges of the future.
Most forward-looking CEOs have already made their move to prepare for the future that they foresee – where business technology is a key deciding factor for them to attain ongoing commercial prosperity. This new digital-propelled environment will profoundly change business processes, al...
For the third year in a row, we worked together with Pacific Crest Securities, an investment banking firm with a specific focus on SaaS, to survey 306 SaaS companies. This represents nearly double the # of respondents from last year, giving us deeper benchmarking data and insights to s...
If you're an executive that's concerned about the high-cost of proprietary software, you're not alone. If your IT team pushes back whenever Line of Business leaders ask them for feature enhancements that goes beyond the limits of the commercial software packages they've licensed, then ...

The Internet of Things: Another Silicon Valley invention to get all excited about? Or is it something that will hold up beyond the California border and next January? If you’re aching to know, then I suggest you attend the upcoming “Monetizing the ‘Internet of Things’” presentation ...

Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE